We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$504B
AUM Growth
+$5.92B
Cap. Flow
-$3.19B
Cap. Flow %
-0.63%
Top 10 Hldgs %
16.49%
Holding
2,620
New
96
Increased
950
Reduced
1,023
Closed
72

Top Buys

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$1.31B
2
HD icon
Home Depot
HD
+$1.07B
3
BABA icon
Alibaba
BABA
+$1.06B
4
YUM icon
Yum! Brands
YUM
+$887M
5
HON icon
Honeywell
HON
+$860M

Top Sells

Rank Stock Value
1
N
Netsuite Inc
N
+$1.59B
2
NXPI icon
NXP Semiconductors
NXPI
+$1.33B
3
DHR icon
Danaher
DHR
+$1.13B
4
HBI
Hanesbrands
HBI
+$1.06B
5
TMO icon
Thermo Fisher Scientific
TMO
+$845M

Sector Composition

Rank Sector Weight
1 Financials 16.86%
2 Healthcare 16.8%
3 Consumer Discretionary 15.02%
4 Technology 13.29%
5 Industrials 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHV icon
2526
Achieve Life Sciences
ACHV
$687M
$23K ﹤0.01%
21
BONT
2527
DELISTED
Bon-Ton Stores Inc/The
BONT
$21K ﹤0.01%
14,200
BLFS icon
2528
BioLife Solutions
BLFS
$1.71B
$19K ﹤0.01%
11,800
ZN
2529
DELISTED
Zion Oil & Gas, Inc.
ZN
$19K ﹤0.01%
14,000
+900
+7% +$1.18K
FNJN
2530
DELISTED
Finjan Holdings, Inc.
FNJN
$18K ﹤0.01%
15,450
FTEK icon
2531
Fuel Tech
FTEK
$45.9M
$16K ﹤0.01%
13,700
FPP.WS
2532
DELISTED
FieldPoint Petroleum Corporation Common Stock Purchase Warrants
FPP.WS
$2K ﹤0.01%
46,200
ALLT icon
2533
Allot
ALLT
$377M
-1,131,402
Closed -$5.96M
ASPN icon
2534
Aspen Aerogels
ASPN
$510M
-2,721,240
Closed -$16.2M
BCE icon
2535
BCE
BCE
$21.6B
-4,765
Closed -$220K
BHC icon
2536
Bausch Health
BHC
$2.32B
-1,722,415
Closed -$42.2M
BNED icon
2537
Barnes & Noble Education
BNED
$417M
-119
Closed -$114K
CTLP
2538
DELISTED
Cantaloupe
CTLP
-24,099
Closed -$135K
EDU icon
2539
New Oriental
EDU
$8.49B
-4,500
Closed -$209K
EPAC icon
2540
Enerpac Tool Group
EPAC
$1.91B
-128,750
Closed -$2.99M
EWZ icon
2541
iShares MSCI Brazil ETF
EWZ
$8.57B
-55,000
Closed -$1.85M
GYRE icon
2542
Gyre Therapeutics
GYRE
$706M
-219
Closed -$30K
HUBS icon
2543
HubSpot
HUBS
$10.5B
-100,401
Closed -$5.79M
IMNN icon
2544
Imunon
IMNN
$6.77M
-27
Closed -$91K
IOVA icon
2545
Iovance Biotherapeutics
IOVA
$3.05B
-480,700
Closed -$3.96M
ITUB icon
2546
Itaú Unibanco
ITUB
$81.6B
-10,572,114
Closed -$51M
MGNX icon
2547
MacroGenics
MGNX
$256M
-8,380
Closed -$251K
MNKD icon
2548
MannKind Corp
MNKD
$1.24B
-18,640
Closed -$58K
NTNX icon
2549
Nutanix
NTNX
$17.5B
-650,000
Closed -$24.1M
PRSO icon
2550
Peraso
PRSO
$10.4M
-6
Closed -$38K

Similar funds

T. Rowe Price Associates's Q4 2016 Portfolio in Review

As of Q4 2016, T. Rowe Price Associates held 2,620 positions worth $504B, up 1.2% from $498B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q4 2016 filing shows 96 new, 950 increased, 1,023 reduced and 72 closed positions. Its largest new stake was Adient: 10,357,941 shares worth $607M. The largest sale was Netsuite Inc, an estimated $1.59B.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q4 2016 buy was Adient: 10,357,941 shares worth $607M.
  • T. Rowe Price Associates added most to Wells Fargo in Q4 2016, an estimated $1.31B increase.
  • T. Rowe Price Associates's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $1.33B.
  • T. Rowe Price Associates fully exited Netsuite Inc in Q4 2016, selling an estimated $1.59B.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $504B portfolio in Q4 2016.
  • T. Rowe Price Associates opened 96 new positions and closed 72 in Q4 2016.
  • T. Rowe Price Associates's portfolio value rose 1.2% quarter-over-quarter to $504B.

Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.